SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

18 Oct 2025 Evaluate
A fair growth of 5.50% in the revenue at Rs. 1816.80 millions was reported in the September 2025 quarter as compared to Rs. 1722.10 millions during year-ago period.The Net Profit of the company reported a remarkable increase of 777.38% to Rs. 368.50  millions  from Rs. 42.00 millions in previous same quarter.The company reported a degrowth in operating Profit to 435.70 millions from 478.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 1816.80 1722.10 5.50 3506.00 3376.30 3.84 6534.30 5820.50 12.26
Other Income 45.40 19.40 134.02 97.70 43.10 126.68 126.80 72.10 75.87
PBIDT 435.70 478.70 -8.98 842.70 893.10 -5.64 1723.30 1353.60 27.31
Interest 1.20 1.70 -29.41 2.50 3.20 -21.88 6.20 4.50 37.78
PBDT 546.70 204.00 167.99 952.40 616.90 54.38 2543.10 1349.10 88.50
Depreciation 52.20 53.10 -1.69 103.60 106.00 -2.26 214.30 170.70 25.54
PBT 494.50 150.90 227.70 848.80 510.90 66.14 2328.80 1178.40 97.62
TAX 126.00 108.90 15.70 217.40 201.30 8.00 496.40 301.80 64.48
Deferred Tax 10.40 1.10 845.45 11.10 -1.60 -793.75 -0.50 -23.60 -97.88
PAT 368.50 42.00 777.38 631.40 309.60 103.94 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.98 27.80 -13.73 24.04 26.45 -9.13 26.37 23.26 13.40

RPG Life Sciences Share Price

2297.45 274.95 (13.59%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×